Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Change in Accured Expenses (2015 - 2025)

Enlivex (ENLV) posted quarterly Change in Accured Expenses of $1.3 million for Q4 2025, up 405.81% year-over-year from $258000.0 in Q4 2024, and up 1025.53% quarter-over-quarter from -$141000.0 in Q3 2025.

Enlivex (ENLV) Change in Accured Expenses (2015 - 2025) Analysis & Trends

Enlivex's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $1.3 million for Q4 2025.

  • In Q4 2025, Change in Accured Expenses rose 405.81% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.1 million (up 202.97% YoY), while the FY2025 annual figure was $1.1 million, up 202.97% from the prior year.
  • Change in Accured Expenses for Q4 2025 stood at $1.3 million, up from -$141000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $1.3 million in Q4 2025, with the low at -$1.0 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $28500.0 (2022), against an average of -$5050.0.
  • The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses surged 485.95% in 2022, then plunged 254.27% in 2023.
  • Enlivex's Change in Accured Expenses stood at $185000.0 in 2021, then soared by 485.95% to $1.1 million in 2022, then slipped by 25.09% to $812000.0 in 2023, then sank by 68.23% to $258000.0 in 2024, then jumped by 405.81% to $1.3 million in 2025.
  • Business Quant data shows ENLV's Change in Accured Expenses at $1.3 million in Q4 2025, -$141000.0 in Q3 2025, and $150000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Enlivex 4.51 Mn -1.25 Mn - 1.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.31 Mn
Dec 31, 2025 1.31 Mn
Sep 30, 2025 -141,000.00
Sep 30, 2025 -141,000.00
Jun 30, 2025 150,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 -239,000.00
Mar 31, 2025 -239,000.00
Dec 31, 2024 258,000.00
Dec 31, 2024 258,000.00
Sep 30, 2024 151,000.00
Sep 30, 2024 151,000.00
Jun 30, 2024 -423,000.00
Jun 30, 2024 -423,000.00
Mar 31, 2024 -1.03 Mn
Mar 31, 2024 -1.03 Mn
Dec 31, 2023 812,000.00
Dec 31, 2023 812,000.00
Sep 30, 2023 227,000.00
Sep 30, 2023 227,000.00